TB Flashcards
what are the radiologic findings in primary TB?
parenchymal involvement
lymphangitis
localized pleural effusion
regional lymphadenitis
what are the radiologic features seen in chronic pulmonary TB?
local exudative TB- most common finding focal, patch heterogenous consolidation local fibroproductive TB Cavitation- hallmark of TB reactivation Tuberculoma
hallmark of TB reactivation
Cavitation
What are the radiologic findings in miliary TB?
stippling in both lungs –> coalesce –> richly stippled pattern (Snowstorm effect)
Advantages of IGRA vs TST
IGRA is not affected by BCG single patient visit result available in 24hrs booster phenomenon does not occur TST used in children less than 5yo
what is most commonly affected in patients with musculoskeletal TB?
vertebral body
what are the 4 basic types of bone lesions in TB osteomyelitis?
cystic- most common in children
infiltrative
focal erosions
expansile lesions
TB of the joints are mostly
monoarticular; large, weight bearing joints
Triad of TB of the joints (phemister)
juxtaarticular osteoporosis
peripherally located osseous erosions
gradual narrowing of interosseous space
findings in TB meningitis (Imaging)
basal cistern hyperdensity (most specific finding)
most common complication of TB meningitis
communicating hydrocephalus
common complication: Ischemic infarct
most effective bactericidal drug
Isoniazid and Rifampicin
most potent sterilizing drug available
Rifampicin
active against rapidly multiplying TB
Pyrazinamide
used together with other drugs to prevent emergence of resistant bacili
Ethambutol
effective in reducing time to culture conversion in adults with MDR-TB
Bedaquilline
drug effective in increasing the proportion of patients achieving sputum culture concentration after 8 weeks treatment
Delamanid
inhibits mycelia acid synthesis
Isoniazid
may cause hepatitis
increased risk of hemolysis in G6PD
peripheral neuropathy
discontinue H&R if with ST/ALT >3x
inhibits DNA-dependent RNA polymerase
Rifampicin
may cause hepatitis, hypersensitivity, thrombocytopenia, orange discoloration of urine
causes disruption of membrane energy metabolism
Pyrazinamide
causes heptotoxicity
requires dose modification in renal toxicity
inhibits transference enzymes involved in cell wall synthesis
Ethambutol
causes peripheral neuropathy and optic neuritis
Fixed dose combinations
Intensive phase: Rifampicin 75mg + Isoniazid 50mg + Pyrazinamide 150mg
Continuation phase: Rifampicin 75mg + Isoniazid 50mg
mother has TB, can she breastfeed?
breastfeeding is encouraged
What to give in pregnant patients with TB
HRZE with pyridoxine (B6) at 25mg/day
pregnant LTBI at high risk of developing active TB
HIV positive
with contact history reveal tubercular conversion in 2yrs
Asymptomatic pregnant with TST positive result with chest xray
give IPT recommended for 9 months; Isoniazid for 6 months with pyridoxine
pregnant with TB disease
1st line drugs safe except Streptomycin, Capreomycin, Ethionamide, Fluoroquinolones, Cycloserine
Newborns of TB mothers:
Mother has LTBI
give BCG
Newborns of TB mothers:
mother has TB disease
if with treatment for 2 weeks or more still rule out congenital TB
If newborn is well, do not give BCG, give IPT x 3 months then perform TST
If TST negative, stop IPT then give BCG
If TST positive, give IPT for 3 months
if mother has EPTB
monitor infant for congenital TB
If suspected to have congenital TB: do TST, chest X-ray, lumbar puncture and appropriate
Even if negative, give treatment
Mother has current TB disease and no treatment received
Infant should be given Isoniazid
If TB isolate is Isoniazid-resistant: give Rifampicin
send placenta for AFB smear
evaluate for congenital TB
If initial TST is negative, repeat after 3 months
IF TST is positive but chest xray is negative, continue Isoniazid or Rifampicin to complete 6 months
If TST and chest xray are negative; completed treatment: give BCG, discontinue H & R
> /=5mm induration TST is positive in the ff:
close contact
chest xray findings suggestive of TB
clinical findings of PTB
immunocompromised state
standard treatment for pregnant women in intensive phase
Isoniazid, rifampicin, pyrazinamide, ethambutol (HRZE x 2mos)
Pyridoxine Vitamin B6 at 25mg/day
breastfeeding encouraged
advise mother to feed baby before taking anti-TB drugs
*streptomycin avoided due to ototoxicity
Treatment for asymptomatic pregnant women with positive TST results, normal chest radiographic findings, and recent contact with contagious person
Isoniazid Preventive Treatment (IPT)
recommended duration is 9 months
begin in the 1st trimester
management of newborn whose mother has latent TB infection (LTBI)
at birth, infant not separated from asymptomatic TST positive mother with negative chest xray; should be given BCG
management of a newborn whose mother has TB disease
IF with TB disease but has undergone treatment for 2 weeks or more, presumed to be no longer infectious.
Possibility of congenital TB should be ruled out
*if newborn is well, do not give BCG first, give IPT for 3 mos then do TST.
- If TST is negative, stop IPT then give BCG
- If TST is positive baby remains well, IPT for 3 mos
- if after 6 mos of IPT, baby remains well give BCG
- If TST is not available and newborn is well, give 6 mod IPT then BCG
- if mother has not received any tx, give Isoniazid
- If maternal TB isolate is Isoniazid-resistant, give Rifampicin instead
- evaluate baby for congenital TB
- if initial TST is negative, repeat after 3mos
- if positive TST but chest xray is negative, Isoniazid or Rifampicin continued for 6 mos
- If TST and chest xray of mother are negative and tx completed, BCG should be given and Isoniazid or Rifampicin discontinued
mother has extrapulmonary disease such as tubercluous meningitis, miliary, bone or joint TB or genitourinary TB
infant must be monitored closely for possible congenital TB
- if suspected to have congenital TB, TST, Chest xray, LP, appropriate cultures
- regardless of TST result, treatment should be initiated promptly
TB in children with liver disease
LFTs should be carried out before initiating anti-TB meds, monitor ALT 2x a week during the 1st 2 weeks
then on a weekly basis until end of second month
and monthly basis thereafter till the end of treatment
- Isoniazid and Rifampicin are potentially hepatotoxic
- total dose of Isoniazid should not be more than 10mg/kg/day
TB in children with drug-induced hepatitis
- in children less than 5 yrs old with elevated transaminases less than 5x normal and asymptomatic, stopping drugs not warranted
- if GI symptoms such as nausea, vomiting, abdominal pain or jaundice noted –>hepatotoxic first-line drugs should be discontinued or modified depending on levels of AST or ALT
Drug induced livery injury definition
AST level 3 or more times than upper limit of normal in presence of symptoms or 5x more than the upper limit in the absence of any symptoms
- AST less than 5x normal = mild toxicity
- AST of 5-10x more than normal is moderate
- AST 10x or more than normal is severe
how can we restart giving of anti-TB meds for patients with drug-induced hepatitis
restarting done slowly
Rifampicin restarted first bec less likely to cause hepatotoxicity; least hepatotoxic
*if no increase in AST after 1 week, may restart Isoniazid
*if symptoms recur, last drug must be stopped
*if severe hepatitis, PZA must be discontinued and replaced by Ethambutol and INH and Rifampicin continued for 9 mos
TB in children with renal impairment
*recommended TB treatment for patients with renal failure or severe renal insufficiency; 2 months HRZE followed by 4 months HR
- Ethambutol 80% cleared by kidney
- streptomycin should be avoided in patients with renal failure
should be measured in all patients with renal disease prior to treatment
Creatinine clearance
- timing of administration is important
- Drugs administered after hemodialysis to prevent loss during dialysis
Antituberculosis drugs that are significantly dependent on renal clearance
Ethambutol Levofloxacin Cycloserine Kanamycin Capreomycin Amikacin streptomycin
*metabolites of pyrazinamide may accumulate
In severe renal impairment with creatinine clearance less than 10ml/min
- reduction of Isoniazid dose to 200mg is recommended
* Ethambutol is given 8hrs before dialysis at 25mg/kg 3x a week when creatinine clearance is between 50 to 100ml/min
cornerstone of diagnostic method for LTBI is
TST
*>5mm cut off for patients with HIV
primary diagnostic test in symptomatic people living with HIV
Xpert MTB/RIF assay
MTB culture remains a necessary diagnostic tool
Primary prophylaxis for TB in children living with HIV
- Children with HIV more than 12 months of age ; unlikely to have TB disease on symptom based screening and have no contact with TB case:
- should be offered 6 months of IPT
confirmed HIV-infected infant and children should receive CTX prophylaxis
- less than 1 year of age regardless of CD4 or clinical status
- children 1-5yrs old diagnosed with WHO stages 2, 3, 4 regardless of CD4 or any WHO stage and CD4 <25%
- less than 6 years diagnosed with any WHO clinical stage and CD4 <350
minor gastrointestinal upset, anorexia, nausea, abdominal pain
Pyrazinamide and Rifampicin
- continue anti-TB drugs, check doses
- Give drugs with small meal or just before going to bed
joint pains
Pyrazinamide
*NSAIDS
Burning sensation, numbness, tingling in the feet /hands
Isoniazid
*Pyridoxine 10mg per 100mg Isoniazid daily
Orange/red unrine
Discolored contact lenses
Rifampicin
*Reassurance
Itching, skin rash
Thioacetazone (streptomycin, Isoniazid, Rifampicin, Pyrazinamide)
*stop anti-TB drugs
deafness
Streptomycin
*stop streptomycin
dizziness, vertigo, nystagmus
Streptomycin
*stop streptomycin,, use ethambutol